Company Description
Samsara Vision is a specialty medical device company dedicated to bringing vision and freedom back to patients suffering from late-stage conditions of the retina.
We are engaged in the research, development, manufacturing, and marketing of proprietary ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders, particularly Age-Related Macular Degeneration (“AMD”).
Our current product line consists of: our first-generation implantable miniature telescope ("IMT"), which we refer to as WA IMT; our Smaller-Incision, New Generation (SING) IMT; and our Tsert delivery system.
Our WA IMT, approved by the FDA in July 2010 and received a Conformité Européenne Mark (“CE Mark”) in August 2005, works similarly to the telephoto lens of a camera, which enables improvement in vision and quality of life for individuals with the most advanced form of AMD.
We received a CE Mark by mdc medical device certification GmbH, an EEA Notified Body for our SING IMT and Tsert delivery system in April 2020 and began commercializing our SING IMT in Europe in 2021.
In addition, we are in the process of establishing the regulatory pathway into the United States.
Country | United States |
Founded | 1997 |
Industry | Health Care Equipment & Supplies |
Sector | Healthcare |
Employees | 20 |
CEO | Thomas Ruggia |
Contact Details
Address: 27 US HWY 202 (Ste 8/9) Far Hills, NJ 07931 United States | |
Phone | (877) 997-4448 |
Website | samsaravision.com |
Stock Details
Ticker Symbol | SMSA |
Exchange | NASDAQ |
Reporting Currency | USD |
CIK Code | 0001824988 |
Employer ID | 47-5178400 |
SIC Code | 3841 |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 30, 2022 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Mar 24, 2022 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Mar 11, 2022 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Jan 20, 2022 | CERT | Certification by an exchange approving securities for listing |
Jan 18, 2022 | 8-A12B | Registration of securities |
Jan 7, 2022 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Dec 23, 2021 | FWP | Free Writing Prospectus |
Dec 17, 2021 | FWP | Free Writing Prospectus |
Dec 17, 2021 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Dec 9, 2021 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |